Five Indiana University researchers have received patents from the U.S. Patent and Trademark Office for cutting-edge technologies and other innovations that they aim to move to market. Below is information about each of the patents. Patent issued to IU innovation that tests cell response to biochemical agents: The U.S. Patent and Trademark Office has issued… Read more »
Tag: neurodegenerative diseases
IU researcher develops new therapy for treatment of ALS
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. Indiana University researcher Chandler Walker, Ph.D., has developed a new stem cell-based secretome therapy that influences both the central and peripheral components of Amyotrophic Lateral Sclerosis pathology. Secretome refers to the secretions of tissue or cells that can be… Read more »